How to Help Your Patients Save Money on Tyenne: A Provider's Guide to Savings Programs

For many patients, the cost of Tyenne (tocilizumab-aazg) is a significant concern — and providers who can navigate savings programs on their patients' behalf play a critical role in keeping patients on therapy. Specialty biologics like Tyenne carry high list prices, but most commercially insured patients — and many uninsured patients — have access to meaningful financial assistance through a layered system of programs.

This guide gives providers a practical framework for understanding and leveraging Tyenne savings resources in 2026, organized by patient insurance status.

Understanding Tyenne's Cost Structure

Tyenne's billing and patient cost structure depends on the formulation:

IV formulation: Typically billed as a "buy and bill" or under a medical benefit. The drug is purchased by the provider or infusion center and administered to the patient. Billed under Medical Benefit (Part B for Medicare). Cost-sharing is based on the patient's deductible and coinsurance.

SC formulation: Dispensed through specialty pharmacy. Billed under Pharmacy Benefit (Part D for Medicare). Subject to the patient's specialty tier copay or coinsurance.

Understanding which benefit (medical vs. pharmacy) applies to your patient's Tyenne is essential, as it determines which savings programs are available and how cost-sharing works.

For Commercially Insured Patients: KabiCare Copay Assistance

The most important savings tool for commercially insured Tyenne patients is the KabiCare Copay Program, offered by Fresenius Kabi. Providers should enroll every eligible patient in this program at the point of prescribing — don't wait for the patient to discover it on their own.

Savings: Eligible commercially insured patients can have their out-of-pocket cost reduced to as little as $0 per prescription. Maximum savings limits apply — verify details at enrollment.

Eligibility: Must have commercial (private) insurance. Not available to Medicare, Medicaid, or other government-funded plan patients.

Enrollment: Call KabiCare at 1-833-522-4227 or visit trialcard.com/fresenius-kabi/kabicopay. Patient registers online or over the phone. Your office can initiate enrollment on behalf of the patient.

Beyond copay assistance: KabiCare also provides benefits investigation, PA support, specialty pharmacy coordination, injection training, and refill reminders — a comprehensive hub service that reduces staff burden and supports adherence.

For Uninsured or Underinsured Patients: Patient Assistance Program

Fresenius Kabi operates a Patient Assistance Program (PAP) for Tyenne for patients who lack insurance or whose insurance does not cover the drug:

Contact: 1-866-316-7263

Income and eligibility criteria apply

Provider must typically complete paperwork (prescription attestation, income documentation from patient)

Processing time is typically 2–4 weeks; plan ahead for new starts when possible

For Medicare Patients: Navigating Part B vs. Part D Costs

Medicare patients present unique financial challenges — and require a different approach:

IV Tyenne (Part B): 20% coinsurance after Part B deductible ($257 in 2025). For high-cost biologics, this can be substantial. Consider whether the patient has supplemental Medigap coverage, which may cover the 20% coinsurance.

SC Tyenne (Part D): Subject to the plan's specialty tier structure. The 2026 Part D out-of-pocket cap is $2,100. Once reached, the plan covers 100% for the rest of the year.

Low Income Subsidy (LIS/Extra Help): For Medicare patients with limited income, the Extra Help program significantly reduces Part D costs. Refer patients who may qualify to the Social Security Administration (SSA) at ssa.gov/extrahelp.

Manufacturer copay card: Cannot be used with Medicare. However, the Fresenius Kabi PAP may be available for qualifying Medicare patients.

Independent Financial Assistance Foundations

When manufacturer programs are unavailable or insufficient, independent nonprofit foundations can fill the gap. These organizations provide disease-specific grants covering copays, premiums, and other costs:

PAN Foundation (panfoundation.org): Provides disease-specific grants to underinsured patients. Check availability of RA, GCA, or autoimmune disease funds — programs open and close based on funding availability.

HealthWell Foundation (healthwellfoundation.org): Offers copay, premium, and deductible assistance. Check for active RA or related disease funds.

Arthritis Foundation: Provides resources to connect RA patients with financial assistance programs. Visit arthritis.org.

NeedyMeds.org: A free database aggregating manufacturer PAPs, state programs, and foundation assistance. Direct patients or staff here for a comprehensive resource.

Practical Workflow: Enrolling Every Tyenne Patient in Savings Programs

Recommended office workflow for new Tyenne prescriptions:

At time of prescribing: Identify insurance type (commercial, Medicare, Medicaid, uninsured).

Commercial patients: Enroll in KabiCare Copay Program (1-833-522-4227 or trialcard.com/fresenius-kabi/kabicopay) at same visit.

Medicare patients: Check for Medigap, LIS eligibility, and the Fresenius Kabi PAP. Also screen for PAN Foundation and HealthWell eligibility.

Uninsured patients: Apply to the Fresenius Kabi PAP (1-866-316-7263). Also check eligibility for ACA marketplace plans if patient may qualify.

All patients: Provide a resource sheet with KabiCare contact, PAN Foundation, HealthWell, and NeedyMeds.

When patients report trouble locating their Tyenne at a specialty pharmacy, medfinder for providers can help your office locate which pharmacies near your patients have the medication available — reducing treatment delays and staff time spent on the phone.

For patient-facing savings information, share: How to Save Money on Tyenne in 2026: Coupons, Discounts, and Patient Assistance.